Skandinaviska Enskilda Banken AB (publ) - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 188 filers reported holding ACORDA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$857,000
+101.2%
420,300
+1845.8%
0.01%
+75.0%
Q2 2017$426,000
-92.4%
21,600
-91.9%
0.00%
-84.6%
Q1 2017$5,624,000
+51.1%
267,800
+35.3%
0.03%
-42.2%
Q4 2016$3,721,000
-9.9%
197,9000.0%0.04%0.0%
Q3 2016$4,132,000
+68.2%
197,900
+105.5%
0.04%
+60.7%
Q2 2016$2,456,00096,3000.03%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 815,838$27,192,0003.30%
ARMISTICE CAPITAL, LLC 186,000$6,199,0002.23%
1492 Capital Management LLC 95,639$3,188,0002.02%
Partner Investment Management, L.P. 19,498$650,0000.91%
Tekla Capital Management LLC 680,862$22,693,0000.82%
PFM Health Sciences, LP 817,396$27,244,0000.69%
HighPoint Advisor Group LLC 11,829$394,0000.61%
ARBOR CAPITAL MANAGEMENT LLC 89,183$2,972,0000.56%
Pergamon Offshore Advisors, L.P. 15,950$532,0000.56%
Penn Capital Management Company, LLC 390,212$13,006,0000.54%
View complete list of ACORDA THERAPEUTICS INC shareholders